Biopharmx Corp., of Menlo Park, Calif., said it will present research suggesting that BPX-01, a topical gel formulation of minocycline, may exhibit relevant antimicrobial and anti-inflammatory properties for the treatment of acne at a conference hosted by the American Society for Cell Biology and European Molecular Biology Organization in Philadelphia.